![Nancy Whiting](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nancy Whiting
Directeur/Membre du Conseil chez
CARIBOU BIOSCIENCES, INC.
Fortune : - $ au 31/05/2026
Profil
Nancy C.
Whiting is Co-President, Chief Executive Officer & Director at Recludix Pharma, Inc. starting in 2026.
Nancy is an Independent Director at Caribou Biosciences, Inc. since 2021 and at Boundless Bio, Inc. since 2023.
Former roles include President, Secretary & Director at Cascadian Therapeutics LLC and Executive VP-Strategy, Alliances & Communications at Seagen, Inc. from 2007 to 2021.
Education includes a doctorate from the University of Washington and an undergraduate degree from the University of British Columbia.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
BOUNDLESS BIO INC. -.--% | 15/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Nancy Whiting
| Sociétés | Poste | Début |
|---|---|---|
| CARIBOU BIOSCIENCES, INC. | Directeur/Membre du Conseil | 24/08/2021 |
| BOUNDLESS BIO, INC. | Directeur/Membre du Conseil | 02/10/2023 |
Recludix Pharma, Inc.
 Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops novel small molecule medicines for inflammatory and immune related diseases | Directeur Général | 01/09/2021 |
Anciens postes connus de Nancy Whiting
| Sociétés | Poste | Fin |
|---|---|---|
| SEAGEN INC. | Public Communications Contact | 01/09/2021 |
| CASCADIAN THERAPEUTICS INC (USA) | President | - |
Formation de Nancy Whiting
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
36
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
Cascadian Therapeutics LLC
 Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Develops therapeutic products for the treatment of cancer | Health Technology |
Caribou Biosciences, Inc.
 Caribou Biosciences, Inc. BiotechnologyHealth Technology Develops technology-based solutions for cellular engineering and analysis | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boundless Bio, Inc.
 Boundless Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that develops cancer therapeutics | Health Technology |
Recludix Pharma, Inc.
Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops novel small molecule medicines for inflammatory and immune related diseases | Commercial Services |
